The NIH Centers for Accelerated Innovations (NCAI) are designed to accelerate translation of scientific discovery into commercial products that improve health for patients. The NIH has created a nationwide network of three Centers located in Boston, Ohio and California merging the strengths of 15 high impact medical research institutions to develop best practices in translating academic innovations into new drugs, devices, and diagnostics.
The NCAI medical technology accelerator program is a unique public-private partnership with expertise and resources from the federal government, academia, and the private-sector that will change the way discoveries with scientific and commercial potential are identified and developed.
Cleveland Clinic and its partners Case Western Reserve University, The Ohio State University, the University of Cincinnati, Cincinnati Children's Hospital Medical Center, and the recently added University of Michigan, have established an NIH Center for Accelerated Innovation (NCAI), headquartered at Cleveland Clinic. The Center will significantly increase the generation of new, patient-benefiting products related to priority targets set by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
Essential to these medical technology accelerator programs is early consideration of commercial issues, and industry-style project management. The result is de-risked technologies with well-designed business cases primed for licensing or startup company formation.
End of main page content.